Dentsply Sirona (XRAY)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$11.38-0.44%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · XRAY
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -32.0% |
| Our one-year growth estimate | diamond | -0.2% |
Growth built into the price is above our model estimate.
The price assumes 31.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 25 industry peers · Company calendar date is not available
XRAY — earnings in line
Dated 2026-05-05
Results of Operations and Financial Condition On May 5, 2026, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its first fiscal quarter ended March 31, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 and an updated GAAP to Non-GAAP reconciliation is furnished as Exhibit 99.2. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1 and 99.2, shall not be deemed “…
Why it matters: Earnings results will show if the company is improving or facing more challenges.
Watch forEarnings report shows revenue growth above 10% year over year.
Also watch forEarnings report shows revenue growth below 0% year over year.
Why it matters: Better operating income shows progress in managing costs. This is very important.
Supportive ifQ2 operating income improves to above -$20M. This means better cost management.
Worry ifQ2 operating income stays below -$35M. This shows ongoing issues with cost management.
Why it matters: The plan aims to make finances stronger. Good execution could help shareholders.
Supportive ifManagement will report on reducing debt or buying back shares soon.
Worry ifDebt levels remain high. No news on share buybacks.
Why it matters: A drop below median growth could signal a broader issue in the health care sector.
Worry ifSector revenue growth falls below its median rate for two consecutive months.
Less concerning ifSector revenue growth stays stable or rises above median rates.
Why it matters: Hitting or beating this EPS would show management can keep their outlook. This is despite revenue pressures.
Supportive ifAdjusted EPS for Q3 meets or exceeds $0.52.
Worry ifAdjusted EPS for Q3 falls below $0.52.
Why it matters: Updates on this plan will show if the company is fixing its problems.
Watch forManagement says they made good progress with distributors and sales.
Also watch forManagement says there are problems or slow progress in the Return-to-Growth Plan.
Why it matters: Growth in cash flow shows the company is improving how it operates.
Supportive ifCash from operations increases to above $50M in Q2.
Worry ifCash from operations drops below $40M in Q2. This shows a setback in cash flow.
Why it matters: Better cash flow means the company is more efficient and in better financial shape.
Supportive ifOperating cash flow reported above $99 million in Q3.
Worry ifOperating cash flow reported below $99 million in Q3.
Why it matters: The company is behind on cost management. Progress could improve financial health.
Supportive ifManagement says the cost management score is above 50%.
Worry ifCost management score is still below 30%.
Why it matters: The new capital allocation strategy aims to improve liquidity and reduce debt. Its success is crucial for financial health.
Watch forThe company reports a decrease in debt by at least $50 million within the next two quarters.
Also watch forDebt levels remain unchanged or increase despite the new strategy.
Why it matters: This plan is important for better financial health and value for shareholders.
Watch forManagement says they successfully cut debt. They also did share buybacks.
Also watch forContinued cash flow issues or failure to reduce debt.
Why it matters: Better cost management could help profits. It would also support the Return-to-Growth Action Plan.
Supportive ifManagement says they saved at least $30M each year from restructuring.
Worry ifCost savings fall short of $30M or restructuring efforts stall.
Why it matters: Improving cash flow from operations is key for growth. Weak cash flow raises concerns.
Supportive ifCash flow from operations is much better, showing a good trend.
Worry ifCash flow from operations declines or remains stagnant.
Why it matters: Updates on this plan will show if Dentsply Sirona can do better.
Supportive ifManagement says they are making good progress in restructuring. They have new ideas.
Worry ifNo updates or bad news on the Return-to-Growth Action Plan.
Why it matters: If adjusted EPS falls below this level, it may show problems in making money.
Worry ifAdjusted EPS was below $1.40.
Less concerning ifAdjusted EPS was above $1.40.
Why it matters: The new CFO's strategies could enhance financial discipline and growth. His effectiveness will be crucial for the company's turnaround.
Watch forQ3 2026 showed good financial results and better margins.
Also watch forQ3 2026 showed continued losses or lower margins.
Why it matters: The new CFO has experience. This could lead to better money management.
Supportive ifLook for positive changes in finances or new plans from the new CFO.
Worry ifThere are no clear signs of better financial results. The company is still losing money.
Why it matters: Adjusted EPS is an important measure of profit. Meeting or beating the guidance shows good cost management.
Supportive ifAdjusted EPS for Q1 2026 is over $0.27. This means better-than-expected profit.
Worry ifAdjusted EPS for Q1 2026 is below $0.27. This suggests ongoing profit issues.
Why it matters: Keeping the dividend shows care for shareholders, even in hard times.
Watch forThe company keeps its quarterly dividend at $0.16 per share this quarter.
Also watch forThe company cuts or stops the quarterly dividend payment.
Why it matters: Growth in this area is important for overall sales recovery. It shows demand for new dental products.
Supportive ifConnected Technology Solutions net sales grow by more than 5% year over year in Q2 2026.
Worry ifConnected Technology Solutions net sales drop or grow less than 1% each year.
Why it matters: This shows if the Return-to-Growth Action Plan is gaining traction or facing more challenges.
Worry ifQ3 net sales decline worse than -4.1% year over year.
Less concerning ifQ3 net sales decline less than -4.1% year over year or grow.
Why it matters: Keeping guidance shows trust in recovery and growth plans.
Supportive ifManagement confirms 2026 net sales guidance of $3.5B to $3.6B. Adjusted EPS is $1.40 to $1.50.
Worry ifManagement cuts 2026 sales or EPS guidance from current levels.
Why it matters: Good cost management can boost profits and help the growth plan.
Supportive ifManagement says it reached big goals for the $120M cost savings target.
Worry ifManagement says there are delays or problems with the cost management plan.
Why it matters: His experience may lead to better finances and growth plans.
Supportive ifGood changes in financial numbers or plans after Fortson took over.
Worry ifFinancial problems or slow progress continue after Fortson took over.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$196 on $10,000 · ±2.0% | How much price usually moves either way. |
| Bad day | $426 loss on $10,000 · 4.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,433 loss on $10,000 · 34.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.